Eddit

Version vom 1. Juni 2020, 19:29 Uhr

• Further reading

32251543 2020. The COVID-19 (Coronavirus) pandemic: reflections on the roles of librarians and information professionals
32379021 2020. Rapid Publication, Knowledge Sharing, and Our Responsibility During the COVID-19 Pandemic

• Unproven ideas

• Reviews on covid19 disease

32170865 ä. Coronavirus disease 2019: What we know?
32096567 ä. Understanding of COVID?19 based on current evidence
32249943 2020. A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults

• Clinical guidelines and advice

32359076 2020. COVID-19: Use of the Clinical Frailty Scale for Critical Care Decisions

32369222 2020. The management of coronavirus disease 2019 (COVID-19)

• Respiration mgmt

32249028 2020. The "helmet bundle" in COVID-19 patients undergoing non invasive ventilation
32268933 2020. Home PAP devices in COVID-19 infected patients

• Diagnosis (Laboratory)

32227490 ä. Performance of VivaDiag COVID?19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID?19 in acute patients referring to emergency room department
32222993 ä. Genomic characterization and phylogenetic analysis of SARS?COV?2 in Italy
32104917 ä. Development and clinical application of a rapid IgM?IgG combined antibody test for SARS?CoV?2 infection diagnosis
32096564 ä. Combination of RT?qPCR testing and clinical features for diagnosis of COVID?19 facilitates management of SARS?CoV?2 outbreak
32243608 ä. Detection of antibodies against SARS?CoV?2 in patients with COVID?19
32270882 2020. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence
32347966 2020. An Evolving Approach to the Laboratory Assessment of COVID-19
32330303 2020. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test
32330291 2020. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience
32320064 2020. Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2)
32311142 2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China

32271278 2020. Integrated Radiologic Algorithm for COVID-19 Pandemic

• Diagnosis (Lung CT, Sonography)

32242947 ä. Imaging and clinical features of patients with 2019 novel coronavirus SARS?CoV?2: A systematic review and meta?analysis
32330305 2020. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
32198775 ä. Is There a Role for Lung Ultrasound During the COVID?19 Pandemic?
32314805 2020. CT imaging features of 4121 patients with COVID-19: A meta-analysis
32195887 2020. Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan
32235187 2020. A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19)

32243920 2020. (18)F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging
32320081 2020. How to Perform Pediatric Lung Ultrasound Examinations in the Time of COVID-19

• Diagnosis (other modalities)

• Structure of covid19

32169673 2020. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species
32349035 2020. Genomic Analysis and Comparative Multiple Sequence of SARS-CoV2
32222995 ä. Phylogenetic analysis of the first four SARS?CoV?2 cases in Chile
32181901 ä. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019?nCoV)
32167180 ä. The establishment of reference sequence for SARS?CoV?2 and variation analysis
32167166 ä. An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human?pathogenic coronavirus (SARS?CoV?2)
32167173 ä. The potential chemical structure of anti?SARS?CoV?2 RNA?dependent RNA polymerase
32159237 ä. From SARS and MERS CoVs to SARS?CoV?2: Moving toward more biased codon usage in viral structural and nonstructural genes
32104911 ä. Evolutionary history, potential intermediate animal host, and cross?species analyses of SARS?CoV?2
32083328 ä. COVID?2019: The role of the nsp2 and nsp3 in its pathogenesis

32314811 2020. Understanding evolution of SARS-CoV-2: a perspective from analysis of genetic diversity of RdRp gene
32311094 2020. Distinct Viral Clades of SARS-CoV-2: Implications for Modeling of Viral Spread
32275073 2020. Response to Ribeiro da Silva et al ,"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2

• Target binding and uptake

32376714 2020. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
32100877 ä. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS?CoV?2
32249956 ä. Structural variations in human ACE2 may influence its binding with SARS?CoV?2 spike protein
32246503 ä. SARS?COV?2 and infectivity: Possible increase in infectivity associated to integrin motif expression
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32374452 2020. SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein
32239522 ä. SARS?CoV?2 spike protein favors ACE2 from Bovidae and Cricetidae

• Cytopathic effects

• Secretion and shedding

• Innate sensing

• Immunology

32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32181911 ä. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID?19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis
32347972 2020. Elevations of serum cancer biomarkers correlate with severity of COVID-19
32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients
32297995 2020. High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients
32281668 2020. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

32343429 2020. Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis

• Pathobiology

32369204 2020. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications
32294295 2020. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

• Disease Models

• Similar diseases and pathomechanisms

32319148 2020. COVID-19: searching for clues among other respiratory viruses
32237148 2020. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center

• Early symptoms

• Systemic disease, any manifestations
• Co-Infection

32196707 ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
32352574 2020. Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
32320082 2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
32293743 2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated
32344469 2020. DIC in COVID-19: Implications for Prognosis and Treatment?
32267998 2020. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

• ARDS

• Pulmonary embolism, coagulation

32311843 2020. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2

32379935 2020. Response to "Lupus anticoagulant is frequent in patients with Covid-19"
32379918 2020. Coagulopathy of COVID-19 and antiphospholipid antibodies
32369666 2020. Incidence of venous thromboembolism in hospitalized patients with COVID-19
32239799 2020. The versatile heparin in COVID-19
32338827 2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19
32302462 2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment
32302442 2020. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19
32220112 2020. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
32302451 2020. Response to Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
32302438 2020. Hypercoagulability of COVID-19 patients in Intensive Care Unit A Report of Thromboelastography Findings and other Parameters of Hemostasis
32271988 2020. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
32344457 2020. Uncertainties on the prognostic value of D-dimers in COVID-19 patients

32329221 2020. Type and dose of heparin in Covid-19: Reply
32329246 2020. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
32324960 2020. Laboratory haemostasis monitoring in COVID-19
32324958 2020. Lupus anticoagulant is frequent in patients with Covid-19
32320517 2020. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
32306492 2020. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
32302456 2020. Potential of heparin and nafamostat combination therapy for COVID-19
32302459 2020. COVID-19 and acute coagulopathy in pregnancy
32302453 2020. Thromboinflammation and the hypercoagulability of COVID-19

32294321 2020. Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis
32294295 2020. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19
32294289 2020. Venous thromboembolism in COVID-19 patients
32293083 2020. Pulmonary thrombosis in 2019-nCoV pneumonia?
32282993 2020. DOACs and newer haemophilia therapies in COVID-19
32281766 2020. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?

• Hematology

32344467 2020. What do monitoring platelet counts in COVID-19 teach us?
32379934 2020. Response to What does monitoring platelet counts in COVID-19 teach us?

32278338 2020. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions

• Heart

32267000 2020. Patterns of heart Injury in COVID - 19 and relation to outcome

• Neurology, ophthalmology, orl

32352575 2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients"
32246783 ä. Response to Commentary on ?The neuroinvasive potential of SARS?CoV?2 may play a role in the respiratory failure of COVID?19 patients?
32374427 2020. Expression of the COVID-19 receptor ACE2 in the human conjunctiva
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32330304 2020. Conjunctivitis and COVID-19: A meta-analysis
32320066 2020. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients
32314810 2020. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)
32311107 2020. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients
32293714 2020. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019
32275079 2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva
32354770 2020. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke
32312873 2020. Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020

• Dermatology

• Gastroenterology, hepatology

32369204 2020. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications
32343413 2020. Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment
32314799 2020. Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab

• Kidney, urology

32249664 2020. Focus on the Crosstalk Between COVID-19 and Urogenital Systems

• Risk and special populations

32222119 ä. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia
32220066 ä. SARS?CoV?2 and HIV
32115733 ä. Coronavirus disease (COVID?19) and neonate: What neonatologist need to know
32160316 ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China
32248565 ä. A twin challenge to handle: COVID?19 with pregnancy
32374416 2020. ACE2 and prognosis of COVID-19 Insights from Bartter s and Gitelman s syndromes patients
32369211 2020. What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
32369203 2020. Smoking links to the severity of Covid-19: An update of a meta-analysis
32221983 2020. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
32266994 2020. Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19"
32266993 2020. Reporting of all cardiac medications and their outcome in COVID - 19
32352576 2020. COVID-19 in pregnancy: risk of adverse neonatal outcomes
32347975 2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey
32343410 2020. COVID-19 in Tuberculosis patients: a report of three cases
32330302 2020. Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"
32293753 2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis
32293709 2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better
32285949 2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)
32374288 2020. Newborns at risk of COVID-19
32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

• The morbid survivor
• Case reports

32343395 2020. Typically Atypical: COVID-19 Presenting as a Fall in an Older Adult
32227488 2020. Diagnosis and treatment of an acute severe pneumonia patient with COVID-19: Case report
32190904 2020. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients

• Case series

32352202 2020. Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019
32222986 ä. Clinical characteristics of 54 medical staff with COVID?19: A retrospective study in a single center in Wuhan, China
32198776 ä. Clinical features and treatment of COVID?19 patients in northeast Chongqing
32167181 ä. Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China
32162702 ä. COVID?19 patients clinical characteristics, discharge rate, and fatality rate of meta?analysis
32162699 ä. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019
32108351 ä. Clinical characteristics of hospitalized patients with SARS?CoV?2 infection: A single arm meta?analysis
32369208 2020. Clinical Features of Patients with Coronavirus Disease 2019 (COVID-19) from a Designated Hospital in Beijing, China
32369217 2020. Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China
32346873 2020. Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection
32297983 2020. Case fatality rate analysis of Italian COVID-19 outbreak
32293716 2020. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis
32293741 2020. Analysis of 92 deceased patients with COVID-19
32281671 2020. Influenza-like illnesses caused by a cluster of imported Italian COVID-19
32275075 2020. Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China
32275074 2020. The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou
32307780 2020. Children may be less affected than adults by novel coronavirus (COVID-19)

• Registries

• Trials

• Candidate Compounds Covid19

32227493 ä. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID?19
32219882 ä. Controversial treatments: An updated understanding of the coronavirus disease 2019
32104907 ä. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus?A possible reference for coronavirus disease?19 treatment option
32108352 ä. Clinical trial analysis of 2019?nCoV therapy registered in China
32379346 2020. ACE2 Activators for the Treatment of Covid 19 Patients
32374457 2020. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections
32369191 2020. Tocilizumab for the treatment of severe coronavirus disease 2019
32356910 2020. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
32232976 2020. CD-sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID-19)
32176361 2020. Potentially repurposing adamantanes for COVID-19
32270515 2020. Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
32253759 2020. Tocilizumab treatment in COVID-19: A single center experience
32347974 2020. Metformin and COVID-19: A novel deal of an Old Drug
32239514 ä. Comments on Zhang et al: Clinical trial analysis of 2019?nCoV therapy registered in China
32236562 2020. Treating COVID-19 with Chloroquine

32320059 2020. Potential of live pathogen vaccines for defeating the COVID-19 pandemic: history and mechanism
32297988 2020. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis
32297985 2020. Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China
32297987 2020. Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection
32293713 2020. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
32285942 2020. Defining Protective Epitopes for COVID-19 Vaccination Models
32281679 2020. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
32302456 2020. Potential of heparin and nafamostat combination therapy for COVID-19

• Other routes of infection

32271653 2020. Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection
32379909 2020. SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes
32222992 ä. Detectable SARS?CoV?2 viral RNA in feces of three children during recovery period of COVID?19 pneumonia
32124995 ä. Fecal specimen diagnosis 2019 novel coronavirus?infected pneumonia
32176356 ä. Is novel coronavirus disease (COVID?19) transmitted through conjunctiva?
32100876 ä. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS?CoV?2 infection
32243607 2020. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients
32239515 ä. Fecal transmission in COVID?19: A potential shedding route

• Biophysics of aerosols

• Passive protective equipment

32320083 2020. Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports

• Running your hospital

32343419 2020. The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China
32312799 2020. Neurointervention for emergent large vessel occlusion during the COVID-19 pandemic
32367764 2020. Vascular access in COVID-19 patients: Smart decisions for maximal safety
32267661 2020. COVID-19 outbreak in Northern Italy: Viewpoint of the Milan area surgical community

• Mental aspects of health professionals

32314806 2020. Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy

• Socio-psychiatric aspects of the status hygienicus

• Avoiding clinical medicine in other diseases

• Occupational medicine, workplace security and status hygienicus
• Economic aspects of the status hygienicus

• Educational aspects of the status hygienicus

• Host, vector, one health, atmospheric aspects

32220068 ä. Might the many positive COVID19 subjects in Italy have been caused by resident bat?derived zoonotic ??coronaviruses instead of the Wuhan (China) outbreak?
32374472 2020. Comments on "Cross-species transmission of the newly identified coronavirus 2019-nCoV"
32346874 2020. SARS-CoV-2 and the Hidden Carriers - Sewage, Feline, and Blood Transfusion

• Origin of Covid19
• Epidemiology

32190908 ä. A doubt of multiple introduction of SARS?CoV?2 in Italy: A preliminary overview
32096566 ä. Early phylogenetic estimate of the effective reproduction number of SARS?CoV?2
32091134 ä. Facing the COVID?19 outbreak: What should we know and what could we do?
32270498 2020. Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa
32270521 2020. Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases
32249944 2020. About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis
32266990 2020. Analyzing situational awareness through public opinion to predict adoption of social distancing amid pandemic COVID-19
32243599 2020. The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis
32330299 2020. Estimating the effects of asymptomatic and imported patients on COVID-19 epidemic using mathematical modeling
32269121 2020. International expansion of a novel SARS-CoV-2 mutant
32329522 2020. Understanding epidemic data and statistics: A case study of COVID-19
32293711 2020. Possibly critical role of wearing masks in general population in controlling COVID-19
32378762 2020. Covid 19 The paradox of social distancing
32362015 2020. The COVID-19 Pandemic Illuminates Persistent and Emerging Disparities among Rural Black Populations

• Remission, recurrence and persistence

32369214 2020. Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies
32270500 2020. Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period
32347980 2020. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon
32330309 2020. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days
32330293 2020. Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection
32311109 2020. Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China
32285947 2020. Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019

• Failure of executive measures

• Failure of politics and public health guidance

32352911 2020. COVID-19 reveals weak health systems by design: Why we must re-make global health in this historic moment

• Political abuse of Covid19

• Lost people

32317499 2020. A tribute to frontline corona warriors--Doctors who sacrificed their life while saving patients during the ongoing COVID-19 pandemic
32238428 2020. Dr Li Wenliang and the Time of COVID-19
32303602 2020. Letter to the Editor: Who was the first doctor to report the Covid-19 outbreak in Wuhan, China?

• Lost civilization

• History of covid19 exploration

32343423 2020. A Novel Plan to Deal with SARS-CoV-2 and COVID-19 Disease

• misc.

32377057 ä. Emerging technologies to combat COVID-19 pandemic
32323591 2020. Immunomodulators and immunosuppressants in the era of SARS-CoV-2 - could laboratory tests be the missing link?
32255383 2020. Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity
32301508 2020. Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks
32281667 2020. Coronavirus disease 2019: new things to know!

• Research tools

32339250 2020. A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019
32275081 2020. Evaluate severe acute respiratory syndrome coronavirus 2 infectivity by pseudoviral particles

• PrePrint scene
• from the ads
• Current state of coviki.org
• on-topic personal thoughts

32338071 2020. Racial Capitalism: A Fundamental Cause of Novel Coronavirus (COVID-19) Pandemic Inequities in the United States
32362015 2020. The COVID-19 Pandemic Illuminates Persistent and Emerging Disparities among Rural Black Populations